Eighth Circuit Deals Blow to Pharmaceutical Industry in 340B Decision
The Eighth Circuit Court of Appeals recently ruled that the State of Arkansas is able to block manufacturers from limiting the…
Author
Amgen Sues Colorado Prescription Drug Affordability Board
Amgen Inc. recently filed a lawsuit in the United States District Court District of Colorado against the State of Colorado’s…
FDA Leaders Illuminate Regulatory Path Forward at Dermatology Meeting in…
By Rick Daigle
\FDA Leaders Illuminate Regulatory Path Forward at Dermatology Meeting in San Diego
At the bustling American…
The Change Healthcare Cyberattack and Its Impact on the U.S. Healthcare…
In early 2024, the U.S. healthcare sector experienced a significant cybersecurity crisis when Change Healthcare, a vital…
Brookings Institution Finds No Surprises Act Arbitration Results in Larger…
The Brookings Institution recently published a study on the outcomes under the No Surprises Act arbitration process, finding that…
Colorado Working to Be Second State to Import Drugs from Canada
Colorado’s General Assembly passed a law in 2019 that allowed the Colorado Department of Health Care Policy and Financing (HCPF)…
Second Circuit Defines “Willful” under Anti-Kickback Statute
The United States Court of Appeals for the Second Circuit recently held that to act “willfully” under the federal Anti-Kickback…
AstraZeneca’s Inflation Reduction Act Lawsuit Rejected
The United States District Court for the District of Delaware recently rejected AstraZeneca’s lawsuit challenging the authority…
Stakeholders Urge DEA to Take Action to Extend Telemedicine Prescribing…
Earlier this year, the Alliance for Connected Care, the American Telemedicine Association, ATA Action, the Consumer Technology…
HHS OIG Issues Favorable Opinion Regarding Patient Assistance Funds…
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently issued Advisory Opinion No. 24-02,…